Amylin Pharmaceuticals to Webcast Year-End Results
January 21 2009 - 4:15PM
PR Newswire (US)
SAN DIEGO, Jan. 21 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Quarterly
Update Conference Call for the fourth quarter and full year 2008 on
Tuesday, January 27, 2009 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M.
Bradbury, Amylin's president and chief executive officer, will lead
the call. On the same date post-market, Amylin will release
financial results for the fourth quarter and year ended December
31, 2008. The call will be webcast live through Amylin's corporate
Web site and a recording will be made available following the close
of the call. To access the webcast, please log on to
http://www.amylin.com/ approximately fifteen minutes prior to the
call to register, download and install any necessary audio
software. For those without access to the Internet, the live call
may be accessed by phone by calling (888) 713-4209 (U.S./Canada) or
(617) 213-4863 (international), Conference ID# 59487694. A replay
of the call will also be available by phone beginning approximately
two hours after the close of the call and can be accessed at (888)
286-8010 (U.S./Canada) or (617) 801-6888 (international),
Conference ID# 22593977. About Amylin Pharmaceuticals Amylin
Pharmaceuticals is a biopharmaceutical company committed to
improving lives through the discovery, development and
commercialization of innovative medicines. Amylin has developed and
gained approval for two first-in-class medicines for diabetes,
SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)
injection. Amylin's research and development activities leverage
the Company's expertise in metabolism to develop potential
therapies to treat diabetes and obesity. Amylin is headquartered in
San Diego, California. Further information on Amylin
Pharmaceuticals is available at http://www.amylin.com/. DATASOURCE:
Amylin Pharmaceuticals, Inc. CONTACT: Michael York, Senior
Director, Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-458-8602 Web Site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024